DUBLIN–(BUSINESS WIRE)–The “E-Pharma Market – Forecasts from 2019 to 2024” report has been added to ResearchAndMarkets.com’s offering.
The global e-pharma market is projected to grow at a CAGR of 19.3% to reach US$72,694 million by 2024, from US$25,212 million in 2018.With rapid internet penetration across the global economy, the adoption of e-commerce model and digital technologies to the pharmaceutical industry is going to be a big game changer in the pharmaceutical markets across the globe. Increasing demand for common drugs, increasing rate of ingestion of medicines, growth in efficient manufacturing technologies and aging population are some of the factors intensely propelling the e-Pharma industry all over the globe.
Europe and North America hold big shares in the market and emerging markets in Asia-Pacific have been showing a high growth rate. This fast growth can be attributed to the availability of skilled labor force and lower labor costs in these markets. However, dealing with stringent government regulations and controlling the sale of unapproved and counterfeit medicines will be some of the challenges this industry is going to face in the coming years.
Drivers
- Growing demand for healthcare products and medicines with the aging population having unmet healthcare needs.
-
Investments in this sector by many players in fastest growing economies like India and China with high internet penetration.
Restraints
- Illegal ePharmacies selling unapproved and counterfeit medicines will make some consumers skeptical.
-
Full internet connectivity and robust infrastructure is still a supply-side issue in emerging markets where demand is high
Recent Developments
- Many firms are going for contract service providers for vertical integration.
- In some firms, there is an effort to set up a symbiotic relationship with coordinated suppliers by major players.
- Procurements and Incorporation are strategies many key players are using. Several new e-Pharmacy start-ups are coming up in emerging economies like India and China attracting significant funding.
Key Topics Covered:
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. KEY FINDINGS
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis – Regional Snapshot
4.7. Market Attractiveness
5. GLOBAL e-PHARMA MARKET BY TYPE
5.1. Prescription
5.2. Non-Prescription
6. GLOBAL e-PHARMA MARKET BY GEOGRAPHY
6.1. North America
6.1.1. USA
6.1.2. Canada
6.1.3. Others
6.2. South America
6.2.1. Brazil
6.2.2. Argentina
6.2.3. Others
6.3. Europe
6.3.1. Germany
6.3.2. United Kingdom
6.3.3. France
6.3.4. Spain
6.3.5. Others
6.4. Middle East and Africa
6.4.1. Israel
6.4.2. UAE
6.4.3. Saudi Arabia
6.4.4. Others
6.5. Asia Pacific
6.5.1. China
6.5.2. South Korea
6.5.3. Japan
6.5.4. India
6.5.5. Others
7. COMPETITIVE INTELLIGENCE
7.1. Competitive Benchmarking and Analysis
7.2. Recent Investments and Deals
7.3. Strategies of Key Players
8. COMPANY PROFILES
8.1. Walmart Stores Inc.
8.2. Walgreen Co.
8.3. Rowlands Pharmacy
8.4. DocMorris
8.5. Pfizer CentreSource
8.6. The Kroger Co.
8.7. Express Scripts Holding Company
8.8. OptumRx Inc.
8.9. CVS Health
For more information about this report visit https://www.researchandmarkets.com/r/r1af5
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceuticals